1. Home
  2. MDXH vs LSE Comparison

MDXH vs LSE Comparison

Compare MDXH & LSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • LSE
  • Stock Information
  • Founded
  • MDXH 2003
  • LSE 2007
  • Country
  • MDXH Belgium
  • LSE China
  • Employees
  • MDXH N/A
  • LSE N/A
  • Industry
  • MDXH
  • LSE Metal Fabrications
  • Sector
  • MDXH
  • LSE Industrials
  • Exchange
  • MDXH Nasdaq
  • LSE Nasdaq
  • Market Cap
  • MDXH 84.6M
  • LSE 86.8M
  • IPO Year
  • MDXH 2021
  • LSE 2024
  • Fundamental
  • Price
  • MDXH $2.00
  • LSE $5.10
  • Analyst Decision
  • MDXH Buy
  • LSE
  • Analyst Count
  • MDXH 1
  • LSE 0
  • Target Price
  • MDXH $6.00
  • LSE N/A
  • AVG Volume (30 Days)
  • MDXH 73.0K
  • LSE 11.1K
  • Earning Date
  • MDXH 05-14-2025
  • LSE 01-01-0001
  • Dividend Yield
  • MDXH N/A
  • LSE N/A
  • EPS Growth
  • MDXH N/A
  • LSE N/A
  • EPS
  • MDXH N/A
  • LSE 0.52
  • Revenue
  • MDXH $94,507,000.00
  • LSE $69,073,374.00
  • Revenue This Year
  • MDXH $23.50
  • LSE N/A
  • Revenue Next Year
  • MDXH $17.30
  • LSE N/A
  • P/E Ratio
  • MDXH N/A
  • LSE $9.76
  • Revenue Growth
  • MDXH 25.46
  • LSE N/A
  • 52 Week Low
  • MDXH $1.35
  • LSE $3.76
  • 52 Week High
  • MDXH $3.50
  • LSE $14.99
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 48.51
  • LSE N/A
  • Support Level
  • MDXH $2.07
  • LSE N/A
  • Resistance Level
  • MDXH $2.21
  • LSE N/A
  • Average True Range (ATR)
  • MDXH 0.12
  • LSE 0.00
  • MACD
  • MDXH -0.02
  • LSE 0.00
  • Stochastic Oscillator
  • MDXH 11.76
  • LSE 0.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About LSE Leishen Energy Holding Co. Ltd. Ordinary Shares

Leishen Energy Holding Co Ltd is a provider of clean-energy equipment and integrated solutions to the oil and gas industry, with a commitment to providing customers with high-performance, safe, and cost-effective energy solutions. The company's business segments include clean-energy equipment; oil and gas engineering technical services; new energy production and operation; and digitalization and integration equipment. A majority of its revenue is generated from the clean-energy equipment segment which supplies various equipments, such as reciprocating compressor units, expansion units, wellhead heating systems, wellhead safety control systems, oil-water separation systems, natural gas online sampling systems, oil and gas skid-mounted equipment, and polymer flexible composite pipes.

Share on Social Networks: